HOME /

Pilot and Feasibility Grant

Next Letter of Intent Deadline

November 20, 2017

Next Application Deadline

January 30, 2018

Pilot & Feasibility Award Program

Download Letter of Intent

Download RFA

Important Dates:

Letters of Intent will be due on or before:  November 20, 2017
Notification of eligibility to proceed with application:  December 7, 2017
Applications will be due on or before:  January 30, 2018

Scope:

The HDDC is focused on the study of epithelial cell function and mucosal biology in inflammation, host defense, and cancer of the gastrointestinal tract and related mucosal surfaces. Pilot & Feasibility projects will be considered for support if they relate directly or indirectly to this mission.

Purposes:

  • Support young investigators who have not previously held independence awards (such as a RO1 and/or PO1) in carrying out independent and promising research that tests a novel research direction or hypothesis. (Type 1 awards)
  • Enable young, developing scientists and/or clinicians to pursue innovative and promising pilot projects which might otherwise not have support, and which ultimately might lead to independent support.
  • Enable established investigators already work ing in digestive disease-related research to make a substantial change in the direction of their research. (Type 2 awards)
  • Entice investigators who have left the field of digestive diseases, or who have never worked in the field, to become involved in research related to digestive diseases. (Type 3 awards)
  • Awards for the PF program by NIH Guidelines is biased to young investigators emerging into independence (Type 1 awards)

Awards:

The HDDC generally makes awards of $25,000 in direct costs, plus 25% F&A costs. The direct costs funding level may vary, however, due to availability of funds and the quality of applications received. Awards will be made for a one-year period, beginning 07/01/2017. A second year of funding will require a competing application.

Letter of Intent/Application:

Please see attached document for details. For questions, please contact: Ms. Amanda Reilly

Please remember to acknowledge the Harvard Digestive Disease Center and NIH grant P30DK034854 in all publications and presentations emerging from HDDC core services, resources, technology, and expertise.